Virginia Drug Discovery Consortium

The Virginia Drug Discovery Consortium (VaDDC) has a threefold mission:

To promote the growth and advancement of drug discovery and development programs at universities and research institutes within Virginia, particularly through inter-institutional collaboration.

To help the pharmaceutical industry bring life-saving and quality of life solutions to patients through innovative collaborations with Virginia’s best and brightest researchers.

To promote and enhance the attractiveness of Virginia as an environment for pharmaceutical and biotech companies.




VirginiaDrugDiscoveryRx: Emerging Targets, Technologies, and Therapeutics for Cancer and Neuroscience

The VaDDC Executive Committee is pleased to announce the VirginiaDrugDiscoveryRx: Emerging Targets, Technologies, and Therapeutics for Cancer and Neuroscience meeting will be held at the Hotel Roanoke – May 21, 22, 2019.

Flyer for details

Register Now Vendor Sponsorships  


  • The VaDDC strives to promote the vibrant drug discovery and development efforts at the research institutions in the state of Virginia.
  • VirginiaDrugDiscoveryRx was a resounding success with 146 attendees from academia, the private sector and government. The meeting showcased the dynamic drug discovery environment in the state of Virginia and focused on the development of public-private drug discovery partnerships, which are foundational to translational research.
  • The recently held VirginiaDrugDiscoveryRx was the 3rd annual meeting organized by the Virginia Drug Discovery Consortium, and followed the highly successful VirginiaBrainRx (2016, Virginia Commonwealth University, Richmond, VA) and VirginiaCancerRx (2017, University of Virginia, Charlottesville, VA).

Thank you to our sponsors whose participation in the  VirginiaDrugDiscoveryRx Symposium held at George Mason University, June 25-26, 2018 was key to the meeting’s success.


Dr. Umesh Desai, VCU, is Awarded a 5 year Grant

The Desai lab has received the “Glycans in Blood Homeostasis and Disease” grant. This is a five-year K12 grant by National Heart, Lung and Blood Institute to train MDs, PhDs and dual degree holders for advanced careers in glycosciences. Only four such K12 grants were...

read more
Virginia Tech
Virginia Biosciences Health Research Corporation
Want to work with us?
If you are interested in supporting this initiative, please contact us.